<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Saudi J Anaesth</journal-id><journal-id journal-id-type="iso-abbrev">Saudi J Anaesth</journal-id><journal-id journal-id-type="publisher-id">SJA</journal-id><journal-title-group><journal-title>Saudi Journal of Anaesthesia</journal-title></journal-title-group><issn pub-type="ppub">1658-354X</issn><issn pub-type="epub">0975-3125</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23493245</article-id><article-id pub-id-type="pmc">3591547</article-id><article-id pub-id-type="publisher-id">SJA-6-323</article-id><article-id pub-id-type="doi">10.4103/1658-354X.105851</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The comparison of Alfentanil and Remifentanil infusion during anesthesia on post-anesthesia recovery</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Entezariasl</surname><given-names>Masood</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Akhavanakbari</surname><given-names>Godrat</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Isazadehfar</surname><given-names>Khatereh</given-names></name><xref ref-type="aff" rid="aff2">1</xref><xref ref-type="corresp" rid="cor1"></xref></contrib></contrib-group><aff id="aff1"><italic>Department of Anesthesiology, EDC Center, Ardabil University of Medical Sciences, Iran</italic></aff><aff id="aff2"><label>1</label><italic>Department of Community &amp; Preventive Medicine, EDC Center, Ardabil University of Medical Sciences, Iran</italic></aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Khatereh Isazadehfar, EDC Center, Ardabil University of Medical Sciences, Iran. E-mail: <email xlink:href="isazadehfar@yahoo.com">isazadehfar@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2012</year></pub-date><volume>6</volume><issue>4</issue><fpage>323</fpage><lpage>326</lpage><permissions><copyright-statement>Copyright: © Saudi Journal of Anaesthesia</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="3009" xml_f="3034" txt_i="11" txt_f="36">Background and Objective:</offsets></title><p><offsets xml_i="3045" xml_f="3400" txt_i="37" txt_f="392">With consideration the daily increased development of outpatient surgeries and high rate of these surgeries in elderly patients, rapid and safe recovery of patients is necessary. In this clinical trial study, recovery time and nausea and vomiting after the use of two rapid-onset narcotics, Alfentanil and Remifentanil, in elderly patients were evaluated.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3431" xml_f="3439" txt_i="394" txt_f="402">Methods:</offsets></title><p><offsets xml_i="3450" xml_f="4450" txt_i="403" txt_f="1403">In this double-blind prospective clinical trial, 40 elderly patients (age above 65 years) candidate to cataract surgery with general anesthesia were studied. The patients were divided randomly into two groups and for first group, 10 μg/kg of Alfentanil was injected and for second group Remifentanil 0.5 μg/kg was injected intravenously during 30 seconds one minute before induction. Both two groups were under general anesthesia with same method and during the anesthesia, first group took infusion of Alfentanil 1 μg/kg/min and second group took Remifentanil 0.1 μg/kg/min. In the end of surgery, the time intervals between end of anesthesia drug administration and spontaneous respiration, eyes opening with stimulation, verbal response and discharge of recovery room, also the incidence of complications related to narcotic drugs, especially nausea and vomiting, was recorded. The data were analyzed in SPSS software using descriptive and analytical statistics such as T-test and chi square test.</offsets></p></sec><sec id="st3"><title><offsets xml_i="4481" xml_f="4489" txt_i="1405" txt_f="1413">Results:</offsets></title><p><offsets xml_i="4500" xml_f="4663" txt_i="1414" txt_f="1577">The time of spontaneous respiration in Alfentanil group was 2 minutes and in Remifentanil group was 3.3 minutes, the difference was not statistically significant (</offsets><italic><offsets xml_i="4671" xml_f="4672" txt_i="1577" txt_f="1578">P</offsets></italic><offsets xml_i="4681" xml_f="4967" txt_i="1578" txt_f="1864">=0.08). The time of eyes opening with stimulation, verbal response, and discharge of recovery room were not significantly different. During recovery, incidence of nausea and vomiting in Remifentanil group (30% of patients) was significantly more than Alfentanil group (5% of patients) (</offsets><italic><offsets xml_i="4975" xml_f="4976" txt_i="1864" txt_f="1865">P</offsets></italic><offsets xml_i="4985" xml_f="4993" txt_i="1865" txt_f="1873">=0.045).</offsets></p></sec><sec id="st4"><title><offsets xml_i="5024" xml_f="5036" txt_i="1875" txt_f="1887">Conclusions:</offsets></title><p><offsets xml_i="5047" xml_f="5354" txt_i="1888" txt_f="2195">Recovery time between Alfentanil and Remifentanil group was not significantly different, but incidence of nausea and vomiting in Remifentanil group was higher than Alfentanil group significantly. It seems that using Alfentanil in the anesthesia for surgical treatment of the elderly people can be preferred.</offsets></p></sec></abstract><kwd-group><kwd><italic>Alfentanil</italic></kwd><kwd><italic>elderly patient</italic></kwd><kwd><italic>general anesthesia</italic></kwd><kwd><italic>nausea and vomiting</italic></kwd><kwd><italic>recovery</italic></kwd><kwd><italic>Remifentanil</italic></kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title><offsets xml_i="5701" xml_f="5713" txt_i="2204" txt_f="2216">INTRODUCTION</offsets></title><p><offsets xml_i="5724" xml_f="6033" txt_i="2217" txt_f="2526">Following laryngoscopy and tracheal intubation, hemodynamic changes in the form of hypertension and tachycardia, cardiac dysrhythmia, catecholamine release, and myocardial ischemia may be seen. These complications cause health-threatening consequences, especially in the patients with cardiovascular disease.[</offsets><xref ref-type="bibr" rid="ref1"><offsets xml_i="6066" xml_f="6067" txt_i="2526" txt_f="2527">1</offsets></xref><offsets xml_i="6074" xml_f="6359" txt_i="2527" txt_f="2812">] Elder person consist higher proportion of people requiring the surgery. These patients usually have lower physiological reserve, variability in autonomic performance, a high prevalence of coexisting cardiovascular diseases, and high sensitivity to the narcotic and anesthetic drugs.[</offsets><xref ref-type="bibr" rid="ref2"><offsets xml_i="6392" xml_f="6393" txt_i="2812" txt_f="2813">2</offsets></xref><offsets xml_i="6400" xml_f="6417" txt_i="2813" txt_f="2830">] The narcotics,[</offsets><xref ref-type="bibr" rid="ref3"><offsets xml_i="6450" xml_f="6451" txt_i="2830" txt_f="2831">3</offsets></xref><offsets xml_i="6458" xml_f="6474" txt_i="2831" txt_f="2847">] vasodilators,[</offsets><xref ref-type="bibr" rid="ref4"><offsets xml_i="6507" xml_f="6508" txt_i="2847" txt_f="2848">4</offsets></xref><offsets xml_i="6515" xml_f="6532" txt_i="2848" txt_f="2865">] beta blockers,[</offsets><xref ref-type="bibr" rid="ref5"><offsets xml_i="6565" xml_f="6566" txt_i="2865" txt_f="2866">5</offsets></xref><offsets xml_i="6573" xml_f="6601" txt_i="2866" txt_f="2894">] calcium channel blockers,[</offsets><xref ref-type="bibr" rid="ref6"><offsets xml_i="6634" xml_f="6635" txt_i="2894" txt_f="2895">6</offsets></xref><offsets xml_i="6642" xml_f="6666" txt_i="2895" txt_f="2919">] volatile anesthetics,[</offsets><xref ref-type="bibr" rid="ref7"><offsets xml_i="6699" xml_f="6700" txt_i="2919" txt_f="2920">7</offsets></xref><offsets xml_i="6707" xml_f="6728" txt_i="2920" txt_f="2941">] local anesthetics,[</offsets><xref ref-type="bibr" rid="ref8"><offsets xml_i="6761" xml_f="6762" txt_i="2941" txt_f="2942">8</offsets></xref><offsets xml_i="6769" xml_f="6787" txt_i="2942" txt_f="2960">] alpha blockers,[</offsets><xref ref-type="bibr" rid="ref9"><offsets xml_i="6820" xml_f="6821" txt_i="2960" txt_f="2961">9</offsets></xref><offsets xml_i="6828" xml_f="6850" txt_i="2961" txt_f="2983">] and benzodiazepines[</offsets><xref ref-type="bibr" rid="ref10"><offsets xml_i="6884" xml_f="6886" txt_i="2983" txt_f="2985">10</offsets></xref><offsets xml_i="6893" xml_f="6939" txt_i="2985" txt_f="3031">] can be used for prevention of these changes.</offsets></p><p><offsets xml_i="6946" xml_f="7216" txt_i="3032" txt_f="3302">The administration of pre-anesthetic narcotics is usually used for tolerating the laryngoscopy and tracheal intubation. Among these, the Alfentanil and Remifentanil have been more increasingly used recently because of their rapid onset effects than any other narcotics.[</offsets><xref ref-type="bibr" rid="ref11"><offsets xml_i="7250" xml_f="7252" txt_i="3302" txt_f="3304">11</offsets></xref><offsets xml_i="7259" xml_f="7260" txt_i="3304" txt_f="3305">]</offsets></p><p><offsets xml_i="7267" xml_f="7572" txt_i="3306" txt_f="3611">Narcotics can increase post-anesthetic nausea and vomiting (PONV) with multiple mechanisms including direct effects on receptors in the vomiting center of the brain stem, vestibular sensitive to vomiting caused by motion, increased gastric secretion, decreased gastric motion and emptying of the stomach.[</offsets><xref ref-type="bibr" rid="ref12"><offsets xml_i="7606" xml_f="7608" txt_i="3611" txt_f="3613">12</offsets></xref><offsets xml_i="7615" xml_f="7876" txt_i="3613" txt_f="3874">] Given the sensitivity to narcotics in the elderly, increasing outpatient surgeries and patients need rapid return to normal condition after surgery; in recent years, more attention to recovery time and incidence of complications in the elderly has been paid.[</offsets><xref ref-type="bibr" rid="ref13"><offsets xml_i="7910" xml_f="7912" txt_i="3874" txt_f="3876">13</offsets></xref><offsets xml_i="7919" xml_f="8142" txt_i="3876" txt_f="4099">] The objective of this study was to compare two narcotics of Alfentanil and Remifentanil in terms of returning time to consciousness following the elimination of anesthesia drugs and PONV incidence in the elderly patients.</offsets></p></sec><sec sec-type="methods" id="sec1-2"><title><offsets xml_i="8195" xml_f="8202" txt_i="4101" txt_f="4108">METHODS</offsets></title><p><offsets xml_i="8213" xml_f="8661" txt_i="4109" txt_f="4557">After the approval of Local Ethical Committee (in 2009) and obtaining written consent from patients to be studied, 40 patients with physical condition of ASA I-III who were volunteers to cataract surgery in Ardabil's Alavi hospital (in Iran) were studied in a double blind prospective clinical trial. Subjects were randomized to A (Alfentanil) and R (Remifentanil) groups by computer-generated codes in closed envelopes opened just before surgery [</offsets><xref ref-type="fig" rid="F1"><offsets xml_i="8691" xml_f="8699" txt_i="4557" txt_f="4565">Figure 1</offsets></xref><offsets xml_i="8706" xml_f="10095" txt_i="4565" txt_f="5951">]. The inclusion criteria for this study were ASA physical class I-III, aged 65-85 years. The exclusion criteria were ASA physical class higher than III, history of respiratory diseases, history of motion sickness, history of PONV, narcotic abuse, hiatal hernia, gastro-esophageal reflux, overweight (BMI&gt;30), being at risk of aspiration, and those having a history of major problem in the previous anesthesia. These trial preparations were prepared by anesthesia nurse who was not involved in the study and who recorded the group randomization separately, such that the anesthesiologist recording the data and caring for the patient was unaware of what the preparation contained. All patients had received ringer 5 ml/ kg and 100% oxygen within 3 minutes before induction of anesthesia. The first group (A) received Alfentanil 10 μg/ kg and the second group (R) received Remifentanil 0.5 μg/kg within 30 seconds. Both drugs were prepared in the syringe with an equal volume and anesthesiologist injector was not aware of the type of medication. Immediately after receiving the primary total dose of narcotics, 0.5 mg/kg Propofol was injected to the patients of both groups, and then continued with 10 mg/s until the decreasing of verbal response. Then, 1 mg/kg Succinylcholine was injected. The patients were ventilated with 0.6 MAC (Minimum Alveolar Concentration) Halothane and 50% O</offsets><sub><offsets xml_i="10100" xml_f="10101" txt_i="5951" txt_f="5952">2</offsets></sub><offsets xml_i="10107" xml_f="10117" txt_i="5952" txt_f="5962"> and 50% N</offsets><sub><offsets xml_i="10122" xml_f="10123" txt_i="5962" txt_f="5963">2</offsets></sub><offsets xml_i="10129" xml_f="11834" txt_i="5963" txt_f="7665">O. To keep the muscle relax, 0.2-0.3 mg/kg Atracurium was injected. During anesthesia, subjects were infused by Alfentanil 1 μg/ kg/ min and 0.1 μg/ kg/min Remifentanil in groups (A) and (R), respectively. Also, both narcotics were prepared in the syringe with an equal volume. The patients received these two drugs in a randomized manner, which had been prepared and blinded with a blinded hospital pharmacy. The patients were monitored using pulse oximetry, heart rate, blood pressure, and electrocardiographic monitoring during anesthesia. At the end of surgery, all of the anesthetic drugs were discontinued and 100% oxygen with 6 l/min was given to them. Following spontaneous respiration of the patients, the neuromuscular block was reversed by 0.025 mg/kg Atropine and 0.05 mg/ kg Neostigmine and patients were extubated after proper position. The period between stopping drugs and returning to the spontaneous respiration was recorded as the respiratory returning time. Then, patients were transferred to recovery room and the intervals were recorded as the time needed between stopping drugs until opening eyes with stimulation and return of verbal response. Finally, the time of stopping of drugs until discharge from recovery room also was recorded. The condition of patients during recovery time was recorded including nausea, vomiting, and respiratory problems. Intense postoperative nausea or existing vomiting was treated with 10 mg Metoclopramide. A power analysis assuming a two-segment difference with a power of 0.9 and α&lt;0.05 indicated a sample size of 20 patients for each group. The data obtained from groups were compared using SPSS and analyzed with T-test and chi square test [</offsets><xref ref-type="fig" rid="F1"><offsets xml_i="11864" xml_f="11872" txt_i="7665" txt_f="7673">Figure 1</offsets></xref><offsets xml_i="11879" xml_f="11881" txt_i="7673" txt_f="7675">].</offsets></p><fig id="F1" position="float"><label><offsets xml_i="11922" xml_f="11930" txt_i="7676" txt_f="7684">Figure 1</offsets></label><caption><p><offsets xml_i="11950" xml_f="11971" txt_i="7684" txt_f="7705">Methodology flowchart</offsets></p></caption><graphic xlink:href="SJA-6-323-g001"></graphic></fig></sec><sec sec-type="results" id="sec1-3"><title><offsets xml_i="12087" xml_f="12094" txt_i="7707" txt_f="7714">RESULTS</offsets></title><p><offsets xml_i="12105" xml_f="12465" txt_i="7715" txt_f="8075">This study had recruited 40 eligible patients into two groups: A (Alfentanil) and R (Remifentanil). They underwent the same surgical treatment and there was no significant difference between two groups regarding age, gender, smoking, systolic, diastolic, and mean arterial blood pressure, heart rates of patients before anesthesia, and duration of anesthesia [</offsets><xref ref-type="table" rid="T1"><offsets xml_i="12497" xml_f="12504" txt_i="8075" txt_f="8082">Table 1</offsets></xref><offsets xml_i="12511" xml_f="12513" txt_i="8082" txt_f="8084">].</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="12561" xml_f="12568" txt_i="8085" txt_f="8092">Table 1</offsets></label><caption><p><offsets xml_i="12588" xml_f="12621" txt_i="8092" txt_f="8125">Basic characteristics of patients</offsets></p></caption><graphic xlink:href="SJA-6-323-g002"></graphic></table-wrap><p><offsets xml_i="12698" xml_f="12909" txt_i="8126" txt_f="8337">The average returning time of respiration after discontinuing of the drugs was noticeably shorter in Alfentanil group (2 minutes) than Remifentanil group (3.3 minutes), but it was not statistically significant (</offsets><italic><offsets xml_i="12917" xml_f="12918" txt_i="8337" txt_f="8338">P</offsets></italic><offsets xml_i="12927" xml_f="13102" txt_i="8338" txt_f="8513">=0.08). There was no significant difference in stopping the anesthesia drugs up to opening eyes, return to verbal response, and discharge from the recovery between two groups.</offsets></p><p><offsets xml_i="13109" xml_f="13267" txt_i="8514" txt_f="8672">There was no respiratory problems with narcotics in recovery time, but the nausea and vomiting which were noticed in both groups were higher in Remifentanil (</offsets><italic><offsets xml_i="13275" xml_f="13276" txt_i="8672" txt_f="8673">n</offsets></italic><offsets xml_i="13285" xml_f="13313" txt_i="8673" txt_f="8701">=6) compared to Alfentanil (</offsets><italic><offsets xml_i="13321" xml_f="13322" txt_i="8701" txt_f="8702">n</offsets></italic><offsets xml_i="13331" xml_f="13343" txt_i="8702" txt_f="8714">=1) groups (</offsets><italic><offsets xml_i="13351" xml_f="13352" txt_i="8714" txt_f="8715">P</offsets></italic><offsets xml_i="13361" xml_f="13372" txt_i="8715" txt_f="8723">&lt;0.05) [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="13404" xml_f="13411" txt_i="8723" txt_f="8730">Table 2</offsets></xref><offsets xml_i="13418" xml_f="13420" txt_i="8730" txt_f="8732">].</offsets></p><table-wrap id="T2" position="float"><label><offsets xml_i="13468" xml_f="13475" txt_i="8733" txt_f="8740">Table 2</offsets></label><caption><p><offsets xml_i="13495" xml_f="13667" txt_i="8740" txt_f="8912">The time average from stopping the anesthetic drugs to return of respiration, eye opening, verbal response and discharge from recovery, and incidence of nausea and vomiting</offsets></p></caption><graphic xlink:href="SJA-6-323-g003"></graphic></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="13793" xml_f="13803" txt_i="8914" txt_f="8924">DISCUSSION</offsets></title><p><offsets xml_i="13814" xml_f="14608" txt_i="8925" txt_f="9719">In this study, we investigated the recovery changes between two groups of elderly patients who had received the narcotics of Alfentanil and Remifentanil. We found that the returning time to spontaneous respiration in Alfentanil group was 1.3 minutes shorter than Remifentanil group, 2 minutes compared to 3.3 minutes, respectively, but this difference was not statistically significant. Moreover, the eyes opening time with stimulus, returning of verbal response, and discharging from recovery had no significant difference between two groups. As regards that both drugs are rapid-onset narcotic, no major differences in the recovery of patients in both groups seems logical. Also, in this study, nausea and vomiting in the Remifentanil group was significantly higher than the Alfentanil group.</offsets></p><p><offsets xml_i="14615" xml_f="14689" txt_i="9720" txt_f="9794">These findings are similar to results obtained from several studies. Wiel </offsets><italic><offsets xml_i="14697" xml_f="14702" txt_i="9794" txt_f="9799">et al</offsets></italic><offsets xml_i="14711" xml_f="14837" txt_i="9799" txt_f="9925">. in comparison of a bolus of 30 μg/ kg of Alfentanil with 2 μg/kg of Remifentanil in direct laryngoscopy without intubation,[</offsets><xref ref-type="bibr" rid="ref11"><offsets xml_i="14871" xml_f="14873" txt_i="9925" txt_f="9927">11</offsets></xref><offsets xml_i="14880" xml_f="14892" txt_i="9927" txt_f="9939">] Schutller </offsets><italic><offsets xml_i="14900" xml_f="14905" txt_i="9939" txt_f="9944">et al</offsets></italic><offsets xml_i="14914" xml_f="15118" txt_i="9944" txt_f="10148">. in comparison of Remifentanil (1.0 μg/kg) and a continuous infusion of 0.5 μg/kg/min, with a loading dose of Alfentanil (25 μg/kg) and a continuous infusion of 1.0 μg/kg/min in major abdominal surgery,[</offsets><xref ref-type="bibr" rid="ref14"><offsets xml_i="15152" xml_f="15154" txt_i="10148" txt_f="10150">14</offsets></xref><offsets xml_i="15161" xml_f="15169" txt_i="10150" txt_f="10158">] Agnew </offsets><italic><offsets xml_i="15177" xml_f="15182" txt_i="10158" txt_f="10163">et al</offsets></italic><offsets xml_i="15191" xml_f="15301" txt_i="10163" txt_f="10273">. in comparison of a bolus of 10 μg/kg of Alfentanil with 1 μg/kg of Remifentanil in outpatient bronchoscopy,[</offsets><xref ref-type="bibr" rid="ref15"><offsets xml_i="15335" xml_f="15337" txt_i="10273" txt_f="10275">15</offsets></xref><offsets xml_i="15344" xml_f="15354" txt_i="10275" txt_f="10285">] Wuesten </offsets><italic><offsets xml_i="15362" xml_f="15367" txt_i="10285" txt_f="10290">et al</offsets></italic><offsets xml_i="15376" xml_f="15561" txt_i="10290" txt_f="10475">. in comparison of Remifentanil (loading dose 1 μg/kg; maintenance infusion, 0.25 μg/kg/min) with Alfentanil (loading dose, 50 μg/kg; maintenance infusion, 1 μg/kg/min) in ENT surgery,[</offsets><xref ref-type="bibr" rid="ref16"><offsets xml_i="15595" xml_f="15597" txt_i="10475" txt_f="10477">16</offsets></xref><offsets xml_i="15604" xml_f="15621" txt_i="10477" txt_f="10494">] and Chinachoti </offsets><italic><offsets xml_i="15629" xml_f="15634" txt_i="10494" txt_f="10499">et al</offsets></italic><offsets xml_i="15643" xml_f="15871" txt_i="10499" txt_f="10727">. in comparison of Remifentanil 1 mg/kg for bolus injection and a continuous infusion of 0.25-0.5 μg/ kg/ min, with Alfentanil 20 μg/kg for bolus injection and a continuous infusion of 0.5-1 μg/kg/min in gynecologic laparoscopy[</offsets><xref ref-type="bibr" rid="ref17"><offsets xml_i="15905" xml_f="15907" txt_i="10727" txt_f="10729">17</offsets></xref><offsets xml_i="15914" xml_f="16003" txt_i="10729" txt_f="10818">] did not observe any significant differences in cases of recovery between the two drugs.</offsets></p><p><offsets xml_i="16010" xml_f="16021" txt_i="10819" txt_f="10830">In Nilsson </offsets><italic><offsets xml_i="16029" xml_f="16034" txt_i="10830" txt_f="10835">et al</offsets></italic><offsets xml_i="16043" xml_f="16053" txt_i="10835" txt_f="10845">.'s study[</offsets><xref ref-type="bibr" rid="ref18"><offsets xml_i="16087" xml_f="16089" txt_i="10845" txt_f="10847">18</offsets></xref><offsets xml_i="16096" xml_f="16720" txt_i="10847" txt_f="11471">] in which 58 patients were randomized to receive Propofol and either Remifentanil or Alfentanil as part of a total intravenous anesthesia reported that the interval between stopping the anesthetic drug and extubation of tracheal tube was 5 minutes longer in Remifentanil group, which is similar to our study. In that study, the time interval between stopping the anesthetic drug and discharge from recovery room was similar between the two groups that confirm our study. The relatively long time to return spontaneous breathing after the infusion of Remifentanil in this study can be due to high-dose infusion of this drug.</offsets></p><p><offsets xml_i="16727" xml_f="16999" txt_i="11472" txt_f="11744">Also, in this study, nausea and vomiting in the Remifentanil group was significantly higher than the Alfentanil group. It may also be associated with the infusion dose of this drug and may require Remifentanil dose adjustment in subsequent studies. In a study by Gazynski </offsets><italic><offsets xml_i="17007" xml_f="17012" txt_i="11744" txt_f="11749">et al</offsets></italic><offsets xml_i="17021" xml_f="17024" txt_i="11749" txt_f="11752">.,[</offsets><xref ref-type="bibr" rid="ref19"><offsets xml_i="17058" xml_f="17060" txt_i="11752" txt_f="11754">19</offsets></xref><offsets xml_i="17067" xml_f="17218" txt_i="11754" txt_f="11905">] the nausea and vomiting rate in Remifentanil group were higher which confirms our study, but these rates were similar in another study by Chinachoti </offsets><italic><offsets xml_i="17226" xml_f="17231" txt_i="11905" txt_f="11910">et al</offsets></italic><offsets xml_i="17240" xml_f="17242" txt_i="11910" txt_f="11912">.[</offsets><xref ref-type="bibr" rid="ref17"><offsets xml_i="17276" xml_f="17278" txt_i="11912" txt_f="11914">17</offsets></xref><offsets xml_i="17285" xml_f="17447" txt_i="11914" txt_f="12076">] that probably this difference is due to studying on gynecological surgery and due to the effect of age and sex of patients on postoperative nausea and vomiting.</offsets></p><p><offsets xml_i="17454" xml_f="17592" txt_i="12077" txt_f="12215">A limitation of our study may be that we did not follow up patients after recovery for assessing of long-term side effects of these drugs.</offsets></p></sec><sec sec-type="conclusion" id="sec1-5"><title><offsets xml_i="17648" xml_f="17658" txt_i="12217" txt_f="12227">CONCLUSION</offsets></title><p><offsets xml_i="17669" xml_f="18105" txt_i="12228" txt_f="12664">Recovery time between Alfentanil and Remifentanil group was not significantly different, but incidence of nausea and vomiting in Remifentanil group was higher than Alfentanil group significantly. It seems that using Alfentanil in the anesthesia for surgical treatment of the elderly people can be preferred. Also, according to high incidence of PONV after using of Remifentanil, we recommend PONV prophylaxis use before using this drug.</offsets></p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>The study was supported by Ardabil Medical University Research Center. We acknowledge the enthusiastic cooperation of Alavi Hospital recovery room nursing staff.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Ardabil University of medical sciences, Iran</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>RD</given-names></name></person-group><source>Anesthesia</source><year>2005</year><edition>5th ed</edition><publisher-loc>USA</publisher-loc><publisher-name>Churchill Livingstone</publisher-name><fpage>1430</fpage><lpage>1</lpage><comment>Chapter 39</comment></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habib</surname><given-names>AS</given-names></name><name><surname>Parker</surname><given-names>JL</given-names></name><name><surname>Maguire</surname><given-names>AM</given-names></name><name><surname>Rowbotham</surname><given-names>DJ</given-names></name><name><surname>Thompson</surname><given-names>JP</given-names></name></person-group><article-title>Effects of Remifentanil and Alfentanil on the cardiovascular response to induction of anesthesia and tracheal intubation in the elderly</article-title><source>Br J Anaesth</source><year>2002</year><volume>88</volume><fpage>430</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">11990278</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhavanakbari</surname><given-names>G</given-names></name><name><surname>Entezariasl</surname><given-names>M</given-names></name><name><surname>Pourfarzi</surname></name></person-group><article-title>Comparison of Remifentanil and Alfentanil effects on the hemodynamic responses to induction of anesthesia and tracheal intubation in elderly patients</article-title><source>Research Journal of Biological Sciences</source><year>2008</year><volume>3</volume><fpage>553</fpage><lpage>6</lpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balakrishnan</surname><given-names>G</given-names></name><name><surname>Raudzens</surname><given-names>P</given-names></name><name><surname>Samra</surname><given-names>SK</given-names></name><name><surname>Sang</surname><given-names>K</given-names></name><name><surname>Boening</surname><given-names>JA</given-names></name><name><surname>Bosek</surname><given-names>V</given-names></name><etal></etal></person-group><article-title>A comparison of Remifentanil and Fentanyl in patients undergoing surgery for intracranial mass lesions</article-title><source>Anesth Analg</source><year>2000</year><volume>91</volume><fpage>163</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10866905</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vocalic</surname><given-names>M</given-names></name><name><surname>Prudy</surname><given-names>GM</given-names></name><name><surname>Elis</surname><given-names>FR</given-names></name></person-group><article-title>Esmolol hydrochloride for the management of the cardiovascular stress response to laryngoscopy and tracheal intubation</article-title><source>Br J Anaesth</source><year>1992</year><volume>68</volume><fpage>529</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">1642945</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovac</surname><given-names>AL</given-names></name></person-group><article-title>Controlling the hemodynamic response to laryngoscopy and endotracheal intubation</article-title><source>J Clin Anesth</source><year>1996</year><volume>8</volume><fpage>63</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">8695083</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedford</surname><given-names>RF</given-names></name><name><surname>And Marshal</surname><given-names>WK</given-names></name></person-group><article-title>Cardiovascular response to endotracheal intubation during four anesthetic techniques</article-title><source>Acta Anaesthesiol Scand</source><year>1984</year><volume>28</volume><fpage>563</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">6496017</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoelting</surname><given-names>RK</given-names></name></person-group><article-title>Blood pressure and heart rate changes during short-duration laryngoscopy for tracheal intubation: Influence of viscose or intravenous lidocaine</article-title><year>1978</year><volume>57</volume><fpage>197</fpage><lpage>9</lpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curran</surname><given-names>J</given-names></name><name><surname>Crowely</surname><given-names>M</given-names></name><name><surname>O’sullivan</surname><given-names>G</given-names></name></person-group><article-title>Deroperidol and endotracheal intubation.Attenuation of pressure response to laryngoscopy and intubation</article-title><source>Anaesthesia</source><year>1980</year><volume>35</volume><fpage>290</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">7396141</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taittonen</surname><given-names>M</given-names></name><name><surname>Kirvela</surname><given-names>O</given-names></name><name><surname>Anata</surname><given-names>R</given-names></name></person-group><article-title>Cardiovascular and metabolic response to clonidine and midazolam premedication</article-title><source>Eur J Anaesthesiol</source><year>1997</year><volume>14</volume><fpage>190</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9088819</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiel</surname><given-names>E</given-names></name><name><surname>Davette</surname><given-names>M</given-names></name><name><surname>Carpentien</surname><given-names>L</given-names></name><name><surname>Fayoux</surname><given-names>P</given-names></name><name><surname>Erb</surname><given-names>C</given-names></name><name><surname>Chevalier</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Comparison of Remifentanil and Alfentanil during anesthesia for patients undergoing direct laryngoscopy without intubation</article-title><source>Br J Anaesth</source><year>2003</year><volume>91</volume><fpage>421</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">12925484</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watcha</surname><given-names>MF</given-names></name><name><surname>White</surname><given-names>PF</given-names></name></person-group><article-title>Postoperative nausea and vomiting</article-title><source>Anesthesiology</source><year>1992</year><volume>77</volume><fpage>162</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">1609990</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>RD</given-names></name><name><surname>Stoelting</surname><given-names>RK</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Miller</surname><given-names>RD</given-names></name><name><surname>Stoelting</surname><given-names>RK</given-names></name></person-group><article-title>Postanesthesia care unit</article-title><source>Basics of Anesthesia</source><year>2000</year><edition>4th ed</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Churchill Livingstone</publisher-name><fpage>435</fpage><lpage>6</lpage><comment>Chapter 31</comment></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schutller</surname><given-names>J</given-names></name><name><surname>Albrecht</surname><given-names>S</given-names></name><name><surname>Breivik</surname><given-names>H</given-names></name><name><surname>Osnes</surname><given-names>S</given-names></name><name><surname>Roberts</surname><given-names>CP</given-names></name><name><surname>Holder</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>A comparison of Remifentanil and Alfentanil in patients undergoing major abdominal surgery</article-title><source>Anaesthesia</source><year>1997</year><volume>52</volume><fpage>307</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">9135180</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agnew</surname><given-names>NM</given-names></name><name><surname>Tan</surname><given-names>NH</given-names></name><name><surname>Scawn</surname><given-names>ND</given-names></name><name><surname>Pennefather</surname><given-names>SH</given-names></name><name><surname>Russell</surname><given-names>GN</given-names></name></person-group><article-title>Choice of opioid supplementation for day-case rigid bronchoscopy: A randomized placebo-controlled comparison of a bolus of Remifentanil and Alfentanil</article-title><source>J Cardiothorac Vasc Anesth</source><year>2003</year><volume>17</volume><fpage>336</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">12827582</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wuesten</surname><given-names>R</given-names></name><name><surname>Vanaken</surname><given-names>H</given-names></name><name><surname>Glass</surname><given-names>P</given-names></name><name><surname>Burekle</surname><given-names>H</given-names></name></person-group><article-title>Assessment of depth of anesthesia and postoperative respiratory recovery after Remifentanil – versus Alfentanil – based total intravenous anesthesia in patients undergoing Ear-Nose-Throat surgery</article-title><source>Anesthesiology</source><year>2001</year><volume>94</volume><fpage>211</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11176083</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinachoti</surname><given-names>T</given-names></name><name><surname>Werawatganon</surname><given-names>T</given-names></name><name><surname>Suksompong</surname><given-names>S</given-names></name><name><surname>Techanivate</surname><given-names>A</given-names></name><name><surname>Kitsampanwong</surname><given-names>W</given-names></name><name><surname>Tansui</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>A multicenter randomized double-blind comparison of Remifentanil and Alfentanil during total intravenous anesthesia for out-patient laparoscopic gynecological procedures</article-title><source>J Med Assoc Thai</source><year>2000</year><volume>83</volume><fpage>1324</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">11215862</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>LB</given-names></name><name><surname>Viby-Mogensen</surname><given-names>J</given-names></name><name><surname>Moller</surname><given-names>J</given-names></name><name><surname>Fonsmark</surname><given-names>L</given-names></name><name><surname>Ostergard</surname><given-names>D</given-names></name></person-group><article-title>Remifentanil vs Alfentanil for direct laryngoscopy</article-title><source>Acta Anaesthesiol Belg</source><year>2003</year><volume>54</volume><fpage>101</fpage></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gazynski</surname><given-names>TM</given-names></name><name><surname>Strzelezyk</surname><given-names>JM</given-names></name><name><surname>Gazynski</surname><given-names>WP</given-names></name></person-group><article-title>Post – anesthesia recovery after infusion of Propofol with Remifentanil or Alfentanil or Fentanyl in morbidly obese patients</article-title><source>Obes Surg</source><year>2004</year><volume>14</volume><fpage>490</fpage><lpage>503</lpage></element-citation></ref></ref-list></back></article>